iShares Neuroscience and Healthcare ETF (IBRN)

NYSEARCA: IBRN · Real-Time Price · USD

30.72

+0.76 (2.52%)

Oct 15, 2026, 4:00 PM EDT - Market closed

Assets	$6.27M
Expense Ratio	0.47%
PE Ratio	18.30
Forward PE	18.48
Shares Out	200,000
Dividend	$0.32 (1.04%)
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Annual
Payout Ratio	19.05%

Volume	n/a
Open	n/a
Previous Close	29.96
Day's Range	n/a
52-Week Low	27.67
52-Week High	43.01
Beta	0.67
Holdings	80
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

Asset Class Equity

Category Health

Region Global

Stock Exchange NYSE Arca

Ticker Symbol IBRN

ETF Provider BlackRock

Index Tracked NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

41.52% of assets

Name	Symbol	Weight
Biogen Inc.	BIIB	5.42%
Neurocrine Biosciences, Inc.	NBIX	4.49%
PTC Therapeutics, Inc.	PTCT	4.43%
Edgewise Therapeutics, Inc.	EWTX	4.42%
Alkermes plc	ALKS	4.36%
argenx SE	ARGX	4.08%
Scholar Rock Holding Corporation	SRRK	3.68%
Dianthus Therapeutics, Inc.	DNTH	3.55%
Supernus Pharmaceuticals, Inc.	SUPN	3.55%
Acadia Pharmaceuticals Inc.	ACAD	3.53%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.31981	Dec 19, 2025
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Full Dividend History

Performance

IBRN had a total return of 12.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.18%.